CT Angiography Source Images Predict Final Infarct Extent in Patients with Basilar Artery Occlusion

References

1. 1.↵
   1. Lindsberg PJ,
   2. Mattle HP

   . Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke 2006;37:922–28

   Abstract/FREE Full Text
2. 2.↵
   1. Schonewille WJ,
   2. Wijman CAC,
   3. Michal P,
   4. et al

   . The basilar artery international cooperation study (BASICS). Int J Stroke 2007;2:220–23

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Hacke W,
   2. Zeumer H,
   3. Ferbert A,
   4. et al

   . Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988;19:1216–22

   Abstract/FREE Full Text
4. 4.↵
   1. Arnold M,
   2. Nedeltchev K,
   3. Schroth G,
   4. et al

   . Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry 2004;75:857–62

   Abstract/FREE Full Text
5. 5.↵
   1. Brandt T,
   2. von Kummer R,
   3. Muller-Kuppers M,
   4. et al

   . Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996;27:875–81

   Abstract/FREE Full Text
6. 6.↵
   1. Dzialowski I,
   2. Hill MD,
   3. Coutts SB,
   4. et al

   . Extent of early ischemic changes on computed tomography (CT) before thrombolysis: prognostic value of the Alberta Stroke Program Early CT Score in ECASS II. Stroke 2006;37:973–78

   Abstract/FREE Full Text
7. 7.↵
   1. Demchuk AM,
   2. Hill MD,
   3. Barber PA,
   4. et al

   . Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA Stroke Study. Stroke 2005;36:2110–15

   Abstract/FREE Full Text
8. 8.↵
   1. Larrue V,
   2. von Kummer RR,
   3. Muller A,
   4. et al

   . Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 2001;32:438–41

   Abstract/FREE Full Text
9. 9.↵
   1. Paciaroni M,
   2. Agnelli G,
   3. Corea F,
   4. et al

   . Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke 2008;39:2249–56

   Abstract/FREE Full Text
10. 10.↵
    1. Coutts SB,
    2. Lev MH,
    3. Eliasziw M,
    4. et al

    . ASPECTS on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke 2004;35:2472–76

    Abstract/FREE Full Text
11. 11.↵
    1. Lev MH,
    2. Segal AZ,
    3. Farkas J,
    4. et al

    . Utility of perfusion-weighted CT imaging in acute middle cerebral artery stroke treated with intra-arterial thrombolysis: prediction of final infarct volume and clinical outcome. Stroke 2001;32:2021–28

    Abstract/FREE Full Text
12. 12.↵
    1. Schramm P,
    2. Schellinger PD,
    3. Klotz E,
    4. et al

    . Comparison of perfusion computed tomography and computed tomography angiography source images with perfusion-weighted imaging and diffusion-weighted imaging in patients with acute stroke of less than 6 hours' duration. Stroke 2004;35:1652–58

    Abstract/FREE Full Text
13. 13.↵
    1. Schwamm LH,
    2. Rosenthal ES,
    3. Swap CJ,
    4. et al

    . Hypoattenuation on CT angiographic source images predicts risk of intracerebral hemorrhage and outcome after intra-arterial reperfusion therapy. AJNR Am J Neuroradiol 2005;26:1798–803

    Abstract/FREE Full Text
14. 14.↵
    1. Puetz V,
    2. Sylaja PN,
    3. Coutts SB,
    4. et al

    . Extent of hypoattenuation on CT angiography source images predicts functional outcome in patients with basilar artery occlusion. Stroke 2008;39:2485–90

    Abstract/FREE Full Text
15. 15.↵
    1. Barber PA,
    2. Hill MD,
    3. Eliasziw M,
    4. et al

    . Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005;76:1528–33

    Abstract/FREE Full Text
16. 16.↵
    1. Fiorelli M,
    2. Bastianello S,
    3. von Kummer R,
    4. et al

    . Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke 1999;30:2280–84

    Abstract/FREE Full Text
17. 17.↵
    1. Thomalla G,
    2. Sobesky J,
    3. Kohrmann M,
    4. et al

    . Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Stroke 2007;38:313–18

    Abstract/FREE Full Text
18. 18.↵
    The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985;312:932–36

    PubMed
19. 19.↵
    1. Schaefer PW,
    2. Yoo AJ,
    3. Bell D,
    4. et al

    . CT angiography-source image hypoattenuation predicts clinical outcome in posterior circulation strokes treated with intra-arterial therapy. Stroke 2008;39:3107–09

    Abstract/FREE Full Text
20. 20.↵
    1. Aviv RI,
    2. Mandelcorn J,
    3. Chakraborty S,
    4. et al

    . Alberta Stroke Program Early CT Scoring of CT perfusion in early stroke visualization and assessment. AJNR Am J Neuroradiol 2007;28:1975–80

    Abstract/FREE Full Text
21. 21.↵
    1. Parsons MW,
    2. Pepper EM,
    3. Chan V,
    4. et al

    . Perfusion computed tomography: prediction of final infarct extent and stroke outcome. Ann Neurol 2005;58:672–79

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Hacke W,
    2. Albers G,
    3. Al-Rawi Y,
    4. et al

    . The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005;36:66–73

    Abstract/FREE Full Text
23. 23.↵
    1. Warach S,
    2. Kaufman D,
    3. Chiu D,
    4. et al

    . Effect of the glycine antagonist gavestinel on cerebral infarcts in acute stroke patients, a randomized placebo-controlled trial: The GAIN MRI Substudy. Cerebrovasc Dis 2006;21:106–11

    PubMed
24. 24.↵
    1. Schulte-Altedorneburg G,
    2. Bruckmann H

    . [Imaging techniques in diagnosis of brainstem infarction]. Nervenarzt 2006;77:731–43; quiz 744

    CrossRefPubMed
25. 25.↵
    1. Lisboa RC,
    2. Jovanovic BD,
    3. Alberts MJ

    . Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke. Stroke 2002;33:2866–71

    Abstract/FREE Full Text
26. 26.↵
    1. Kang K,
    2. Yoon BW

    . Symptomatic intracerebral hematomas in posterior circulation stroke patients anticoagulated with heparin. J Thromb Thrombolysis 2006;21:249–55

    CrossRefPubMedWeb of Science